Heart Failure

This heart failure channel offers news and new technology to treat heart failure. This includes for new innovations to treat congestive heart failure (CHF). The channel includes news on HFpEF and HFrEF. Heart failure occurs when the heart is no longer able to pump as much blood as the body requires. This can lead to enlargement of the heart because the muscle works harder to supply blood, but the pumping is ineffective. This may be due to defects in the myocardium, such as an infarct, or due to structural issues such as severe valve regurgitation. The disease is divided into four New York Heart Association (NYHA) classes. Stage IV heart failure is when the heart is completely failing and requires a heart transplant or a left ventricular assist device (LVAD).

News | Diagnostic and Interventional Cardiology DAIC

Happy Holidays from DAIC

December 25, 2022 — The Diagnostic and Interventional Cardiology (DAIC) team wishes you a very happy holiday season and ...

December 25, 2022

Individuals with coronary artery disease exist on a spectrum of disease, such as the amount of plaque build-up in the arteries of the heart; however, the disease is conventionally classified as broad categories of case (yes disease) or control (no disease), which may result in misdiagnosis. A digital marker for coronary artery disease derived from machine learning and electronic health records can better quantify where an individual falls on the disease spectrum. Credit: Icahn School of Medicine at Mount Si

News | Heart Failure

Digital Marker for Coronary Artery Disease Built by Researchers at Mount Sinai

December 22, 2022 — Using machine learning and clinical data from electronic health records, researchers at the Icahn ...

December 22, 2022

Arrow International, LLC, a Subsidiary of Teleflex, Inc, recalls Arrow AutoCAT 2, AC3 intra-aortic balloon pumps for unexpectedly short battery run times

Feature | Intra-Aortic Balloon Pumps (IABP)

Teleflex Recalls Arrow Intra-Aortic Balloon Pumps for Short Battery

The U.S. Food and Drug Administration (FDA) has issued a Class I recall on the Arrow AutoCAT 2 and AC3 Intra-Aortic ...

December 20, 2022

Sponsored Content

Blog | Artificial Intelligence

BLOG: AI outperforms human analysis in predicting cardiac outcomes

New research shows superiority of Ultromics’ AI in predicting cardiac-related death As the use of artificial ...

October 10, 2022

Late-breaking clinical trials for the American College of Cardiology’s Annual Scientific Session Together with World Congress of Cardiology (ACC.23/WCC) have been announced.

Feature | ACC | By Melinda Taschetta-Millane

ACC 2023 Late-breaking Clinical Trials Announced

Late-breaking clinical trials for the American College of Cardiology’s Annual Scientific Session Together with World ...

December 20, 2022

suPAR overexpression leads to increased atherosclerotic and necrotic plaques in a murine model of atherosclerosis. WT (n = 18) and suPARTg (n = 21) mice were maintained on a low-fat diet until 3 months of age and were then transfected with Pcsk9-AAV and fed a western diet (WD) for 10 weeks. At this point, aortic roots were obtained, paraffin embedded, and stained with H&E and Mac2 (galectin 3). (A) Cross sections of aortic roots from C57BL/6 WT and suPARTg mice show total lesion area, outlined in dashed lin

News | Heart Failure

New Immune Target to Treat Cardiovascular Disease Discovered

December 16, 2022 — For the longest time, clinicians have treated cardiovascular disease by focusing on diabetes and ...

December 16, 2022

Doctors from the Emory Heart & Vascular Center are joining forces with the Family Heart Foundation, a leading research and advocacy organization, to find and more widely treat undiagnosed patients living with a common genetic condition that causes very high levels of unhealthy cholesterol, heightening the risk for heart attacks and strokes even at a young age.

News | STEMI

Emory Doctors and Family Heart Foundation Team Up to Help Patients with Dangerously High Cholesterol Caused by Genetic Condition

December 15, 2022 — Doctors from the Emory Heart & Vascular Center are joining forces with the Family Heart Foundation ...

December 15, 2022

From left, Qian Ma, PhD, and Yuqing Huo, MD, PhD. Photo courtesy of Michael Holahan, Augusta University

News | Heart Failure

New Target in the Fight Against Heart Disease

December 15, 2022 — Soon after cholesterol and fat start depositing on the lining of the blood vessels that supply your ...

December 15, 2022

Edwards Lifesciences identified the top data releases from 2022 that contributed most to shaping awareness about the extent and impact of underdiagnosis and undertreatment of aortic stenosis (AS).

News | Heart Valve Technology

Edwards Identifies Top Data Releases of 2022 that Highlight the Impacts of Aortic Stenosis Undertreatment

December 14, 2022 — Edwards Lifesciences identified the top data releases from 2022 that contributed most to shaping ...

December 14, 2022

Series to feature leading experts discussing the current and future trends in the carotid treatment market

News | Stents Carotid

InspireMD Announces “12 Days of Carotid Stenting” Video Series Featuring Fireside Chats with Top Multidisciplinary Vascular Specialists

December 13, 2022 — InspireMD, Inc., developer of the CGuard Embolic Prevention Stent System (EPS) for the prevention of ...

December 13, 2022

Image courtesy of Intermountain Healthcare

News | Cardiovascular Clinical Studies

Study Finds Patients Without Standard Modifiable Heart Risk Factors Are Common and More Likely to Fare Better After Heart Attack Than Patients with Known Factors

December 13, 2022 — A new study by researchers at Intermountain Healthcare in Salt Lake City finds that patients without ...

December 13, 2022

US-based Weill Cornell Medicine has initiated a new clinical project together with the Mwanza International Trials Unit located in the Lake Zone of Tanzania with the aim of exploring the burden of arrhythmia in adults with and without HIV.

News | Artificial Intelligence

Weill Cornell Medicine partners with Poland-based company Cardiomatics to investigate the relationship between HIV and heart rhythm disorders

December 12, 2022 — US-based Weill Cornell Medicine has initiated a new clinical project together with the Mwanza ...

December 12, 2022

Dr. Rami Kahwash, director of Ohio State’s Heart and Vascular Research Organization and a professor of clinical medicine in the Ohio State College of Medicine.

News | Cardiovascular Clinical Studies

Ohio State First in World to Participate in Trial Confirming Efficacy of Novel Heart Failure Treatment

December 9, 2022 — The Ohio State University Wexner Medical Center is first in the world to randomize a patient in a ...

December 09, 2022

Bempedoic acid becomes the first ATP citrate lyase inhibitor and first oral non-statin to meet the major adverse cardiovascular events (MACE-4) primary endpoint

News | Cardiovascular Clinical Studies

Esperion Announces CLEAR Cardiovascular Outcomes Trial of NEXLETOL (bempedoic acid) Meets Primary Endpoint

December 8, 2022 — Esperion announced that the landmark Cholesterol Lowering via Bempedoic acid, an ACL-Inhibiting Regim ...

December 08, 2022

Brian Arends, left, checks the electrical resistivity and conductivity of the wearable heart monitor as Zheng Yan, center, and Yadong Xu, right, observe in Yan's lab. The lab is located in the Roy Blunt NextGen Precision Health building. Pate McCuien/University of Missouri

News | Wearables

University of Missouri Researchers Design New Heart Health Wearable

December 7, 2022 — While heart disease is a leading cause of death in the United States, most people can be treated ...

December 07, 2022

News | Clinical Decision Support

Computerized Decision Support System Helps to Reduce Cardiovascular Risk Factors in Patients with Diabetes

December 7, 2022 — Compared with team-based care alone, the addition of a computerized clinical decision support system ...

December 07, 2022